Showing results (1-10 of 326) with videos related to
Sort By:
Pageof 33
Cell|April 11, 2015
Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potentialPadmanee Sharma, James P AllisonScience (New York, N.Y.)|April 4, 2015
The future of immune checkpoint therapyPadmanee Sharma, James P AllisonScience Translational Medicine|November 9, 2022
Immune checkpoint therapy: Forging aheadPadmanee Sharma, James P AllisonSeminars in Oncology|March 27, 2007
Immunotherapeutic strategies for high-risk bladder cancerPadmanee Sharma, Lloyd J Old, James P AllisonNature Reviews. Cancer|October 25, 2011
Novel cancer immunotherapy agents with survival benefit: recent successes and next stepsPadmanee Sharma, Klaus Wagner, Jedd D Wolchok, et al.The Journal of Experimental Medicine|April 2, 2014
Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapyXiaozhou Fan, Sergio A Quezada, Manuel A Sepulveda, et al.Cancer Journal (Sudbury, Mass.)|April 26, 2016
Immune Checkpoint Therapy and the Search for Predictive BiomarkersPadmanee SharmaThe Journal of Experimental Medicine|March 22, 2024
ICOS costimulation in combination with CTLA-4 blockade remodels tumor-associated macrophages toward an antitumor phenotypeNaveen Sharma, Xiaozhou Fan, Oluwatomisin T Atolagbe, et al.Cancer Immunology Research|April 30, 2014
Increased frequency of ICOS+ CD4 T cells as a pharmacodynamic biomarker for anti-CTLA-4 therapyDerek Ng Tang, Yu Shen, Jingjing Sun, et al.Cancer Discovery|April 3, 2021
The Next Decade of Immune Checkpoint TherapyPadmanee Sharma, Bilal A Siddiqui, Swetha Anandhan, et al.Pageof 33